Next Article in Journal

Efficacy of Immune Checkpoint Inhibitors vs. Tyrosine Kinase Inhibitors/Everolimus in Adjuvant Renal Cell Carcinoma: Indirect Comparison of Disease-Free Survival

Previous Article in Journal

Biomarker Analysis from a Phase I/Ib Study of Regorafenib and Nivolumab in Mismatch Repair-Proficient Advanced Refractory Colorectal Cancer

Previous Article in Special Issue

Developing Cardio-Oncology Programs in the New Era: Beyond Ventricular Dysfunction Due to Cancer Treatments

You seem to have javascript disabled. Please note that many of the page functionalities won't work as expected without javascript enabled.

Search for Articles:

Title / Keyword

Author / Affiliation / Email

Journal

Article Type

Advanced Search

Section

Special Issue

Volume

Issue

Number

Page

Logical OperatorOperator

Search Text

Search Type

Submit to this Journal Review for this Journal Propose a Special Issue

Article Menu

Share Help Cite Discuss in SciProfiles

Open AccessArticle

Article Versions Notes

Cancers 2024, 16(3), 558; https://doi.org/10.3390/cancers16030558

Action	Date	Notes	Link
article pdf uploaded.	28 January 2024 09:30 CET	Version of Record	https://www.mdpi.com/2072-6694/16/3/558/pdf-vor
article supplementary file uploaded.	28 January 2024 09:30 CET	-	https://www.mdpi.com/2072-6694/16/3/558#supplementary
article xml file uploaded	29 January 2024 06:33 CET	Original file	-
article xml uploaded.	29 January 2024 06:33 CET	Update	https://www.mdpi.com/2072-6694/16/3/558/xml
article pdf uploaded.	29 January 2024 06:33 CET	Updated version of record	https://www.mdpi.com/2072-6694/16/3/558/pdf
article html file updated	29 January 2024 06:34 CET	Original file	https://www.mdpi.com/2072-6694/16/3/558/html

Back to TopTop